Among the 26 INS patients in the active phase, 21 (81%) were positive for co-localization of IgG and nephrin, whereas all three patients with monogenic nephrotic syndrome and all 17 patients with other kidney diseases were negative for co-localization. The gene discussed is NPHS1; the disease is nephrotic syndrome.